title: Authors' response to letter by A. Mazarati.
authors.affiliation: Departments of Pediatrics, Neurology and Pharmaceutical Sciences, Children's Hospital Colorado, University of Colorado Schools of Medicine and Pharmacy, Aurora, Colorado, U.S.A. amy.brooks-kayal@childrens-colorado.org.
authors.forename: Amy R
authors.initials: AR
authors.lastname: Brooks-Kayal
authors.forename: Kevin G
authors.initials: KG
authors.lastname: Bath
authors.forename: Anne T
authors.initials: AT
authors.lastname: Berg
authors.forename: Aristea S
authors.initials: AS
authors.lastname: Galanopoulou
authors.forename: Gregory L
authors.initials: GL
authors.lastname: Holmes
authors.forename: Frances E
authors.initials: FE
authors.lastname: Jensen
authors.forename: Andres M
authors.initials: AM
authors.lastname: Kanner
authors.forename: Terence J
authors.initials: TJ
authors.lastname: O'Brien
authors.forename: Vicky H
authors.initials: VH
authors.lastname: Whittemore
authors.forename: Melodie R
authors.initials: MR
authors.lastname: Winawer
authors.forename: Manisha
authors.initials: M
authors.lastname: Patel
authors.forename: Helen E
authors.initials: HE
authors.lastname: Scharfman
mesh_terms: D000818:Animals; D003072:Cognition Disorders / Q000188:drug therapy*; D055808:Drug Discovery; D015507:Drugs, Investigational / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D019965:Neurocognitive Disorders / Q000188:drug therapy*
chemical_list: D015507:Drugs, Investigational